Laurie Havanec - CVS Health Ex Officer
| CVSH34 Stock | BRL 35.68 0.44 1.22% |
Insider
Laurie Havanec is Ex Officer of CVS Health
| Age | 62 |
| Phone | 401-765-1500 |
| Web | https://www.cvshealth.com |
Laurie Havanec Latest Insider Activity
Tracking and analyzing the buying and selling activities of Laurie Havanec against CVS Health stock is an integral part of due diligence when investing in CVS Health. Laurie Havanec insider activity provides valuable insight into whether CVS Health is net buyers or sellers over its current business cycle. Note, CVS Health insiders must abide by specific rules, including filing SEC forms every time they buy or sell CVS Health'sshares to prevent insider trading or benefiting illegally from material non-public information that their positions give them access to.
Laurie Havanec over six months ago Disposition of 6698 shares by Laurie Havanec of CVS Health at 76.43 subject to Rule 16b-3 |
CVS Health Management Efficiency
The company has return on total asset (ROA) of 0.0418 % which means that it generated a profit of $0.0418 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.0568 %, meaning that it generated $0.0568 on every $100 dollars invested by stockholders. CVS Health's management efficiency ratios could be used to measure how well CVS Health manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Showing other executives | INSIDER Age | ||
| Katie CFA | Cognizant Technology Solutions | N/A | |
| Lee Hodges | Apartment Investment and | N/A | |
| John Kim | Cognizant Technology Solutions | 55 | |
| Christian Schnitzlein | Unipar Carbocloro SA | N/A | |
| Christian Schnitzlein | Unipar Carbocloro SA | N/A | |
| Rodrigo Salles | Unipar Carbocloro SA | N/A | |
| Mauricio Russomanno | Unipar Carbocloro SA | N/A | |
| John Nicholson | Apartment Investment and | N/A | |
| Mauricio Russomanno | Unipar Carbocloro SA | N/A | |
| Derek Ullian | Apartment Investment and | N/A | |
| Matt Konrad | Apartment Investment and | N/A | |
| Matt Foster | Apartment Investment and | N/A | |
| Lawrence Wieser | Cognizant Technology Solutions | N/A | |
| Tom Marchant | Apartment Investment and | N/A | |
| Jan Siegmund | Cognizant Technology Solutions | 59 | |
| Stephanie WernerDietz | ArcelorMittal SA | 51 | |
| Rashmi Vasisht | Cognizant Technology Solutions | N/A | |
| Jennifer Johnson | Apartment Investment and | 50 | |
| H Stanfield | Apartment Investment and | 47 | |
| Nicola Davidson | ArcelorMittal SA | N/A | |
| Rajesh MCA | Cognizant Technology Solutions | 55 | |
Management Performance
| Return On Equity | 0.0568 | |||
| Return On Asset | 0.0418 |
CVS Health Leadership Team
Elected by the shareholders, the CVS Health's board of directors comprises two types of representatives: CVS Health inside directors who are chosen from within the company, and outside directors, selected externally and held independent of CVS. The board's role is to monitor CVS Health's management team and ensure that shareholders' interests are well served. CVS Health's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, CVS Health's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Thomas Moriarty, Executive Vice President General Counsel, Chief Health Strategy Officer | ||
| Tilak Mandadi, Digital Data | ||
| Shawn Guertin, Ex CFO | ||
| Larry McGrath, Sr Relations | ||
| James Clark, Controller VP | ||
| Alan MD, Ex Services | ||
| David Falkowski, Ex Officer | ||
| Norman Greve, Chief Officer | ||
| Laurie Havanec, Ex Officer | ||
| Karen Lynch, CEO Pres |
CVS Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is CVS Health a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.0568 | |||
| Return On Asset | 0.0418 | |||
| Profit Margin | 0.01 % | |||
| Operating Margin | 0.05 % | |||
| Current Valuation | 971.11 B | |||
| Shares Outstanding | 12.84 B | |||
| Price To Earning | 46.57 X | |||
| Price To Book | 1.86 X | |||
| Price To Sales | 2.16 X | |||
| Revenue | 322.47 B |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Other Information on Investing in CVS Stock
CVS Health financial ratios help investors to determine whether CVS Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in CVS with respect to the benefits of owning CVS Health security.